S'identifier

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

7.8K Views

09:38 min

June 26th, 2019

DOI :

10.3791/59473-v

June 26th, 2019

7,771 Views

Transcription

Explorer plus de vidéos

Afatinib Resistance
JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2024 MyJoVE Corporation. Tous droits réservés.